{"transactions":[{"id":739194,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:15:45.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":13980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":13980,"derivative":{"exercise_price":26.82,"expiration_date":"2036-06-10","underlying":"Ordinary Shares","underlying_shares":13980},"source":{"system":"sec-edgar","filing":"0000904454-26-000339","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000339/edgar.xml","form_type":"4"}},{"id":739193,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-12T21:15:45.000Z","date":"2026-06-11","kind":"sale","planned":false,"acquired":false,"shares":1993,"price":27.06,"value":53930.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":33903,"source":{"system":"sec-edgar","filing":"0000904454-26-000339","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000339/edgar.xml","form_type":"4"}},{"id":739192,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-12T21:15:45.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":7550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":35896,"source":{"system":"sec-edgar","filing":"0000904454-26-000339","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000339/edgar.xml","form_type":"4"}},{"id":767483,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T21:06:49.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234857","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234857/ownership.xml","form_type":"4"}},{"id":767482,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T21:06:49.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":11383,"source":{"system":"sec-edgar","filing":"0001193125-26-234857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234857/ownership.xml","form_type":"4"}},{"id":1102394,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-24T21:50:02.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":2112,"price":14.45,"value":30518.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":28346,"source":{"system":"sec-edgar","filing":"0000904454-25-000334","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445425000334/edgar.xml","form_type":"4"}},{"id":1111023,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:55:00.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":15630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":15630,"derivative":{"exercise_price":16.22,"expiration_date":"2035-06-11","underlying":"Ordinary Shares","underlying_shares":15630},"source":{"system":"sec-edgar","filing":"0000904454-25-000314","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445425000314/edgar.xml","form_type":"4"}},{"id":1111022,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-13T20:55:00.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":7970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":30458,"source":{"system":"sec-edgar","filing":"0000904454-25-000314","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445425000314/edgar.xml","form_type":"4"}},{"id":1127192,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T20:30:09.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080308","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080308/ownership.xml","form_type":"4"}},{"id":1127191,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:09.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025."}],"balance_after":7583,"source":{"system":"sec-edgar","filing":"0000950170-25-080308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080308/ownership.xml","form_type":"4"}},{"id":1471728,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T20:57:40.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":15840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":15840,"derivative":{"exercise_price":4.57,"expiration_date":"2034-06-19","underlying":"Ordinary Shares","underlying_shares":15840},"source":{"system":"sec-edgar","filing":"0000904454-24-000395","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445424000395/edgar.xml","form_type":"4"}},{"id":1471727,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-21T20:57:40.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":8080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":22488,"source":{"system":"sec-edgar","filing":"0000904454-24-000395","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445424000395/edgar.xml","form_type":"4"}},{"id":1476871,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-17T22:42:43.000Z","date":"2024-06-13","kind":"sale","planned":false,"acquired":false,"shares":2221,"price":5.14,"value":11415.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14408,"source":{"system":"sec-edgar","filing":"0000904454-24-000362","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445424000362/edgar.xml","form_type":"4"}},{"id":1494779,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-03T20:29:27.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":2783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2024, 2,783 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 30, 2024, 2,783 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":2783,"source":{"system":"sec-edgar","filing":"0000950170-24-068014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024068014/ownership.xml","form_type":"4"}},{"id":1508576,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-20T20:58:21.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":2783,"derivative":{"exercise_price":45.92,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":2783},"source":{"system":"sec-edgar","filing":"0001209191-24-005674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919124005674/doc4.xml","form_type":"4"}},{"id":1532701,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value $0.0001 per share","published_at":"2024-05-01T01:45:06.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":479569892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive one ordinary share, par value $0.0001. 50% of the RSUs shall vest on March 28, 2025, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":1018027792,"source":{"system":"sec-edgar","filing":"0000950170-24-050854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000095017024050854/ownership.xml","form_type":"4"}},{"id":1848846,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T21:33:15.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":17060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":17060,"derivative":{"exercise_price":20.18,"expiration_date":"2033-06-13","underlying":"Ordinary Shares","underlying_shares":17060},"source":{"system":"sec-edgar","filing":"0000904454-23-000404","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445423000404/edgar.xml","form_type":"4"}},{"id":1848845,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T21:33:15.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":2301,"price":18.76,"value":43166.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F3","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.74 to $18.85. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16629,"source":{"system":"sec-edgar","filing":"0000904454-23-000404","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445423000404/edgar.xml","form_type":"4"}},{"id":1848844,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T21:33:15.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":18930,"source":{"system":"sec-edgar","filing":"0000904454-23-000404","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445423000404/edgar.xml","form_type":"4"}},{"id":1882155,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-22T20:27:28.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest 100% on the one year anniversay from the date of grant."}],"balance_after":5300,"derivative":{"exercise_price":9.96,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-23-031467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919123031467/doc4.xml","form_type":"4"}},{"id":1982981,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-03-01T21:11:47.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":384,"price":20.02,"value":7687.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.01 to $20.03. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10230,"source":{"system":"sec-edgar","filing":"0000899243-23-006575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000089924323006575/doc4.xml","form_type":"4"}},{"id":2226688,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T21:03:32.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":17810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":17810,"derivative":{"exercise_price":14.08,"expiration_date":"2032-06-15","underlying":"Ordinary Shares","underlying_shares":17810},"source":{"system":"sec-edgar","filing":"0000904454-22-000364","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445422000364/edgar.xml","form_type":"4"}},{"id":2226687,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-17T21:03:32.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":10614,"source":{"system":"sec-edgar","filing":"0000904454-22-000364","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445422000364/edgar.xml","form_type":"4"}},{"id":2263149,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2022-05-19T18:41:04.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":79600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":79600,"derivative":{"exercise_price":0.33,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":79600},"source":{"system":"sec-edgar","filing":"0001209191-22-030447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122030447/doc4.xml","form_type":"4"}},{"id":2368333,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-28T23:10:18.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":2645,"derivative":{"exercise_price":16.04,"expiration_date":"2032-02-24","underlying":"Ordinary Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0000904454-22-000187","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445422000187/edgar.xml","form_type":"4"}},{"id":2368332,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-02-28T23:10:18.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":1534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":1534,"source":{"system":"sec-edgar","filing":"0000904454-22-000187","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445422000187/edgar.xml","form_type":"4"}},{"id":2536112,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-23T00:09:26.000Z","date":"2021-10-21","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests over three years, with one-third vesting on the first anniversary of the date of grant and the remainder vesting quarterly on a pro-rata basis during the remainder of the vesting period, provided that the Stock Option shall vest fully no later than the date of the Issuer's 2024 Annual General Meeting of Shareholders, subject to the Reporting Person's continued relationship with the Issuer through each such date."}],"balance_after":10000,"derivative":{"exercise_price":28.24,"expiration_date":"2031-10-21","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000904454-21-000721","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445421000721/edgar.xml","form_type":"4"}},{"id":2662898,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:42:07.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":58200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a special retention award comprised of options to purchase common stock. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":58200,"derivative":{"exercise_price":2.07,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":58200},"source":{"system":"sec-edgar","filing":"0001209191-21-041461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919121041461/doc4.xml","form_type":"4"}},{"id":2662897,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:42:07.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":58200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":58200,"derivative":{"exercise_price":2.07,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":58200},"source":{"system":"sec-edgar","filing":"0001209191-21-041461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919121041461/doc4.xml","form_type":"4"}},{"id":2788624,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-15T09:15:19.000Z","date":"2021-03-15","kind":"disposition_to_issuer","acquired":false,"shares":7358,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition of options to purchase Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated January 31, 2021 (the \"Merger Agreement\"), by and among the Issuer, Horizon Therapeutics USA, Inc., Teiripic Merger Sub, Inc. (\"Purchaser\"), and for certain purposes, Horizon Therapeutics plc, including the completion on March 13, 2021 of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $53.00 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Purchaser on on March 15, 2021. Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was held by a non-employee director of the Issuer, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was held by a non-employee director of the Issuer, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was held by a non-employee director of the Issuer, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."}],"balance_after":0,"derivative":{"exercise_price":48.96,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":7358},"source":{"system":"sec-edgar","filing":"0000899243-21-011496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734517/000089924321011496/doc4.xml","form_type":"4"}},{"id":2788623,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-15T09:15:19.000Z","date":"2021-03-15","kind":"disposition_to_issuer","acquired":false,"shares":14716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition of options to purchase Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated January 31, 2021 (the \"Merger Agreement\"), by and among the Issuer, Horizon Therapeutics USA, Inc., Teiripic Merger Sub, Inc. (\"Purchaser\"), and for certain purposes, Horizon Therapeutics plc, including the completion on March 13, 2021 of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $53.00 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Purchaser on on March 15, 2021. Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was held by a non-employee director of the Issuer, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was held by a non-employee director of the Issuer, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was held by a non-employee director of the Issuer, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."}],"balance_after":0,"derivative":{"exercise_price":48.96,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":14716},"source":{"system":"sec-edgar","filing":"0000899243-21-011496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734517/000089924321011496/doc4.xml","form_type":"4"}},{"id":3100471,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T16:47:51.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":7358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant vests on the first anniversary date of the grant."}],"balance_after":7358,"derivative":{"exercise_price":48.96,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":7358},"source":{"system":"sec-edgar","filing":"0001209191-20-038741","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734517/000120919120038741/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-23"}},{"id":3100470,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T16:47:51.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":14716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant vests in equal installments of shares on the anniversary date of the grant for the next three years: June 19, 2021, June 19, 2022 and June 19, 2023."}],"balance_after":14716,"derivative":{"exercise_price":48.96,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":14716},"source":{"system":"sec-edgar","filing":"0001209191-20-038741","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734517/000120919120038741/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-23"}},{"id":3101455,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-23T16:41:24.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":14716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant vests in equal installments of shares on the anniversary date of the grant for the next three years; June 19, 2021, June 19, 2022 and June 19, 2023."}],"balance_after":14716,"derivative":{"exercise_price":48.96,"expiration_date":"2030-06-19","underlying":"Common Stock","underlying_shares":14716},"source":{"system":"sec-edgar","filing":"0001209191-20-038485","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734517/000120919120038485/doc4.xml","form_type":"4"}},{"id":3136490,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2020-05-22T19:00:15.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":40500,"derivative":{"exercise_price":7.3,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001209191-20-031661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120031661/doc4.xml","form_type":"4"}},{"id":3475841,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2019-06-28T20:05:00.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":33300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":33300,"derivative":{"exercise_price":7.31,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":33300},"source":{"system":"sec-edgar","filing":"0001209191-19-039467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119039467/doc4.xml","form_type":"4"}},{"id":3560044,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2019-04-08T20:41:59.000Z","date":"2019-04-05","kind":"grant","acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":68000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-05","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001209191-19-023975","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119023975/doc4.xml","form_type":"4"}}]}